Pharmacological activity and protein phosphorylation caused by nitric oxide-releasing microparticles

Biomaterials

Volumn 31, Issue 3, 2010, Pages 552-558

  Yoo, Jin Wook ^a   Choe, Eun Sang ^b   Ahn, Sung Min ^b   Lee, Chi H ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Pusan National University   (South Korea)

Author keywords

Blood flow; Cell viability; NO releasing microparticles; PKC; Protein phosphorylation

Indexed keywords

BLOOD FLOW; CELL VIABILITY; NO-RELEASING MICROPARTICLES; PKC; PROTEIN PHOSPHORYLATION;

AGRICULTURAL PRODUCTS; EMULSIFICATION; ENZYME ACTIVITY; HEMODYNAMICS; NITRIC OXIDE; PHOSPHORYLATION;

BLOOD;

DIETHYLENETRIAMINE DIAZENIUMDIOLATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE DONOR; POLYGLACTIN; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG FORMULATION; DRUG MECHANISM; DRUG SCREENING; DRUG STABILITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EVAPORATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; ORGAN BLOOD FLOW; ORGAN PERFUSION; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; VAGINA; WESTERN BLOTTING;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG COMPOUNDING; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HYDROGEN-ION CONCENTRATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATERIALS TESTING; MOLECULAR STRUCTURE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; VAGINA;

RATTUS;

EID: 70449127049     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.09.058     Document Type: Article

References (37)

1. Akaike T., and Maeda H. Nitric oxide and virus infection. Immunology 101 3 (2000) 300-308
2. Cannon R.O. Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem 44 8 (1998) 1809-1819
3. Traub O., and Van Bibber R. Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications. West J Med 162 5 (1995) 439-445
4. D'amati G., di Gioia C.R.T., Bologna M., Giordano D., Giorgi M., Dolci S., et al. Type 5 phosphodiesterase expression in the human vagina. Urology 60 1 (2002) 191-195
5. Kim S.W., Jeong S.J., Munarriz R., Kim N.N., Goldstein I., and Traish A.M. Role of the nitric oxide-cyclic GMP pathway in regulation of vaginal blood flow. Int J Impot Res 15 5 (2003) 355-361
6. Pacher P., Mabley J.G., Liaudet L., Evgenov O.V., Southan G.J., Abdelkarim G.E., et al. Topical administration of a novel nitric oxide donor, linear polyethylenimine-nitric oxide/nucleophile adduct (DS1), selectively increases vaginal blood flow in anesthetized rats. Int J Impot Res 15 6 (2003) 461-464
7. Uckert S., Ehlers V., Nuser V., Oelke M., Kauffels W., Scheller F., et al. In vitro functional responses of isolated human vaginal tissue to selective phosphodiesterase inhibitors. World J Urol 23 6 (2005) 398-404
8. Yoo J.W., Acharya G., and Lee C.H. In vivo evaluation of vaginal films for mucosal delivery of nitric oxide. Biomaterials 30 23-24 (2009) 3978-3985
9. Hrabie J.A., Klose J.R., Wink D.A., and Keefer L.K. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 58 6 (1993) 1472-1476
10. Yoo J.W., Lee J.S., and Lee C.H. Characterization of nitric oxide-releasing microparticles for the mucosal delivery. J Biomed Mater Res A (2009) 10.1002/jbm.a.32434
11. Clarke S.J., Khaliulin I., Das M., Parker J.E., Heesom K.J., and Halestrap A.P. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ Res 102 9 (2008) 1082-1090
12. House S.L., Melhorn S.J., Newman G., Doetschman T., and Schultz J.E.J. The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2. Am J Physiol Heart Circ Physiol 293 1 (2007) 354-365
13. Li R.C.X., Ping P., Zhang J., Wead W.B., Cao X., Gao J., et al. PKCe modulates NF-kB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 279 4 (2000) 1679-1689
14. Kawata H., Yoshida K., Kawamoto A., Kurioka H., Takase E., Sasaki Y., et al. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C ε{lunate} in the rat ischemic myocardium. Circ Res 88 7 (2001) 696-704
15. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 5240 (1995) 1326-1331
16. Ping P., Zhang J., Cao X., Li R.C.X., Kong D., Tang X.L., et al. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol Heart Circ Physiol 276 5 (1999) 1468-1481
17. Punn A., Mockridge J.W., Farooqui S., Marber M.S., and Heads R.J. Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes. Biochem J 350 Pt 3 (2000) 891-899
18. Giuliano F., Allard J., Compagnie S., Alexandre L., Droupy S., and Bernabe J. Vaginal physiological changes in a model of sexual arousal in anesthetized rats. Am J Physiol Regul Integr Comp Physiol 281 1 (2001) R140-149
19. Kim N.N., Stankovic M., Armagan A., Cushman T.T., Goldstein I., and Traish A.M. Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat. BMC Womens Health 6 (2006) 14
20. Vachon P., Simmerman N., Zahran A.R., and Carrier S. Increases in clitoral and vaginal blood flow following clitoral and pelvic plexus nerve stimulations in the female rat. Int J Impot Res 12 1 (2000) 53-57
21. Park K., Goldstein I., Andry C., Siroky M.B., Krane R.J., and Azadzoi K.M. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 9 1 (1997) 27-37
22. Basson R., Berman J., Burnett A., Derogatis L., Ferguson D., Fourcroy J., et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163 3 (2000) 888-893
23. Traish A.M., Kim N.N., Munarriz R., Moreland R., and Goldstein I. Biochemical and physiological mechanisms of female genital sexual arousal. Arch Sex Behav 31 5 (2002) 393-400
24. Paumelle R., Tulasne D., Leroy C., Coll J., Vandenbunder B., and Fafeur V. Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells. Mol Biol Cell 11 11 (2000) 3751-3763
25. Fryer R.M., Wang Y., Hsu A.K., and Gross G.J. Essential activation of PKC-d in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 280 3 (2001) 1346-1353
26. Nordstrom E., Fisone G., and Kristensson K. Opposing effects of ERK and p38-JNK MAP kinase pathways on formation of prions in GT1-1 cells. FASEB J 23 2 (2009) 613
27. Park K.S., Ahn Y., Kim J.A., Yun M.S., Seong B.L., and Choi K.Y. Extracellular zinc stimulates ERK-dependent activation of p21(Cip/WAF1) and inhibits proliferation of colorectal cancer cells. Br J Pharmacol 137 5 (2002) 597-607
28. Sanna P.P., Simpson C., Lutjens R., and Koob G. ERK regulation in chronic ethanol exposure and withdrawal. Brain Res 948 1-2 (2002) 186-191
29. Takahashi A., Day N.K., Luangwedchakarn V., Good R.A., and Haraguchi S. A retroviral-derived immunosuppressive peptide activates mitogen-activated protein kinases 1. J Immunol 166 11 (2001) 6771-6775
30. Whitmarsh A.J., Yang S.H., Su M.S., Sharrocks A.D., and Davis R.J. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol 17 5 (1997) 2360-2371
31. Choi W.S., Chun S.Y., Markelonis G.J., Oh T.H., and Oh Y.J. Overexpression of calbindin-D28K induces neurite outgrowth in dopaminergic neuronal cells via activation of p38 MAPK. Biochem Biophys Res Commun 287 3 (2001) 656-661
32. Leppa S., Saffrich R., Ansorge W., and Bohmann D. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBP J 17 (1998) 4404-4413
33. Li H.L., Chen D.D., Li X.H., Zhang H.W., Lu Y.Q., Ye C.L., et al. Changes of NF-kB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: role of reactive oxygen species. World J Gastroenterol 8 3 (2002) 431-435
34. Liu Y., Guyton K.Z., Gorospe M., Xu Q., Lee J.C., and Holbrook N.J. Differential activation of ERK, JNK/SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite. Free Radic Biol Med 21 6 (1996) 771-781
35. Griess P. Bemerkungen zu der Abhandlung der HH. Weselsky und Benedikt "Ueber einige azoverbindungen". Chem Ber 12 1 (1879) 426-428
36. Simpson J.N., and McGinty J.F. Forskolin induces preproenkephalin and preprodynorphin mRNA in rat striatum as demonstrated by in situ hybridization histochemistry. Synapse 19 3 (1995) 151-159
37. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76 9 (1979) 4350-4354